Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $40,025 - $45,177
209 Added 11.58%
2,014 $427,000
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $26,269 - $28,875
140 Added 8.41%
1,805 $347,000
Q1 2023

May 12, 2023

BUY
$127.59 - $203.08 $212,437 - $338,128
1,665 New
1,665 $337,000
Q2 2022

Aug 12, 2022

BUY
$108.81 - $179.33 $147,655 - $243,350
1,357 New
1,357 $240,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Fund Management At Engine No. 1 LLC Portfolio

Follow Fund Management At Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.